Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-09-07 11:37 am Sale | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | Malin Life Sciences Holdings Ltd | 2,109,425 4.560% | -280,554 (-11.74%) | View |
| 2022-02-10 4:55 pm Purchase | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | Malin Life Sciences Holdings Ltd | 2,389,979 5.450% | 30,554 (+1.29%) | View |
| 2021-10-15 1:17 pm Purchase | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | Malin Life Sciences Holdings Ltd | 2,359,425 5.390% | 2,359,425 (New Position) | View |
| 2021-02-03 06:15 am Purchase | 13G | Poseida Therapeutics Inc. PSTX | Malin Life Sciences Holdings Ltd | 9,188,125 14.900% | 9,188,125 (New Position) | View |